Document Type

Conference Proceeding

Publication Date

3-8-2022

Publication Title

J Am Coll Cardiol

Abstract

Background: 18-F-fluorodeoxyglucose positron emission tomography (FDG-PET) plays an important role in the diagnosis and management of cardiac sarcoidosis (CS). False positive study can be seen in conditions that increase myocardial FDG uptake or due to artifacts.

Case: An 83-year-old male with mitral regurgitation who underwent Tendyne Transmitral Valve Implantation was referred for FDG-PET due to bilateral hilar lymphadenopathy on recent CT. FDG-PET showed moderate area of severely decreased perfusion involving the distal lateral wall and apical wall at rest. There was increased FDG uptake in the distal lateral and apical wall on the attenuation corrected images (AC) that was not present on the non-AC images.

Decision-making: FDG accumulation in myocardial tissue is only indicative of increased cellular metabolic activity and is not specific for CS. Several reports of non-specific FDG uptake around prosthetic cardiac valves and devices have been reported. Although the uptake pattern in this case was consistent with active CS, it became apparent that this was an artifact due to the Tendyne prosthesis after the CT data of the Tendyne valve location was co-registered with the FDG data.

Conclusion: FDG-PET is frequently used in diagnosing active CS and for disease monitoring. When interpreting the images, taking into consideration the clinical context, patient’s history and supporting data is vital to avoid misdiagnosis. Thus, going to basics of integrating all data cannot be over-emphasized.

Volume

79

Issue

9

First Page

3087

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.